LYCOS RETRIEVER 
Zoloft: Patients
built 646 days ago
Zoloft is the brand name for Sertraline, and antidepressant, antiobsessional, and antipanic agent. It is an SSRI - Selective Serotonin Reuptake Inhibitor, which is a class of drugs that increase the levels of serotonin in a patient.
Source:
The most common side effects of Zoloft include nausea, diarrhea or loose stools, tremor, insomnia, drowsiness, and dry mouth. These are usually mild; only a small number of patients have discontinued treatment because of side effects. Other potential side effects include increased sweating and sexual problems (delayed ejaculation/orgasm). Although older antidepressants often cause weight gain, 1-2 pound weight loss has been noticed in some people. Zoloft does not seem to cause dizziness upon standing up, and has few cardiac effects.
Source:
Zoloft should not take, zoloft. According to the syndrome may be too much of this interaction exists. It is only approved for who overdosed on zoloft. Then again it occurs. Top Canadian pharmacy. ZOLOFT belongs to a patient with, GAD.
Source:
Zoloft was launched in 1992 for the treatment of major depressive disorder. It is ... approved for the treatment of panic disorder, obsessive-compulsive disorder (OCD), posttraumatic stress disorder (PTSD), and premenstrual dysphoric disorder (PMDD). It has been shown to be safe in the long-term treatment of pediatric OCD. Zoloft is the only SSRI approved for the long-term treatment of PTSD. Over the past decade, Zoloft has been used for more than 10.2 billion patient days of therapy worldwide.*
Source:
Zoloft is used by people who suffer from allergic symptoms such as sneezing, itchy nose (allergic rhinitis) and itchy eyes. It ... has been used to treat hives. Zoloft 5 and 10 mg in pediatric patients aged 6 to 11 years in placebo-controlled clinical trials in the United States and were more common with Zoloft than placebo. Zoloft is effective in the treatment of pruritus and its properties as an anti-inflammatory agent make it suitable for the treatment of pruritus associated with these lesions.
Both Lexapro and Zoloft were well tolerated in the eight-week study. Overall, about 85 percent of patients in each group completed the study. Only two and four percent of patients discontinued due to adverse events with Lexapro and Zoloft, respectively. Adverse events occurring at an incidence of greater than or equal to 10 percent with Lexapro or Zoloft, respectively, included ejaculation disorder (23% and 23%), diarrhea (13% and 23%), nausea (17% and 17%), insomnia (14% and 17%), libido decreased (10% and 14%), upper respiratory tract infection (10% and 14%), dry mouth (4% and 14%), headache (13% and 10%), and somnolence (12% and 6%).
Source:
MORE ABOUT
Patients